Stock Events

Stock Events

Frelii 

$0.000100
4
+$0.00+0% Thursday 20:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0001
52W Low
0.00001
Volume
7,603
Avg. Volume
1,668
Mkt Cap
5,346.8
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

14NovExpected
Q1 2018
Q1 2018
Q2 2018
Q3 2018
Q1 2019
Q2 2019
Q3 2019
-0.06
-0.04
-0.03
-0.01
Expected EPS
N/A
Actual EPS
-0.06

Financials

-15,416.67%Profit Margin
Unprofitable
2013
2014
2015
2016
2017
2018
36,000Revenue
-5.55MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing with Frelii's genomics-based technology.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences offers long-read sequencing technologies, competing in the genomic analysis space similar to Frelii.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health focuses on liquid biopsies and cancer diagnostics through genomic insights, competing in the personalized medicine space with Frelii.
Fulgent Genetics
FLGT
Mkt Cap539.57M
Fulgent Genetics provides comprehensive genetic testing, directly competing with Frelii in the genomics-based health solutions market.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen offers sample to insight solutions including molecular diagnostics and genomic services, competing in the same space as Frelii.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a wide range of services in the genetic analysis field, including sequencing, making it a competitor.
Bionano Genomics
BNGO
Mkt Cap13.78M
Bionano Genomics focuses on genomic analysis and mapping, offering competitive technologies for genetic research similar to Frelii.
Intellia Therapeutics
NTLA
Mkt Cap1.8B
Intellia Therapeutics is involved in CRISPR gene editing, a cutting-edge genomic technology that competes with Frelii's offerings.
Editas Medicine
EDIT
Mkt Cap485.31M
Editas Medicine works on gene editing using CRISPR, competing in the genomic medicine space by offering alternatives to traditional genetic analysis.

About

Frélii, Inc. specializes in delivering personalized, subscription-based health and wellness programs. Through its frelii.com web platform, the company designs individual health assessments and tailored nutrition plans. These plans are meticulously developed by analyzing a comprehensive range of personal data, including genetic information, physiological markers, environmental influences, lifestyle choices, and diagnostic lab results. Additionally, the platform facilitates access to various related health products, such as diagnostic testing kits, custom-compounded pharmacy items, and a selection of nutritional and vitamin supplements. Formerly operating as Vican Resources, Inc., the organization rebranded to Frélii, Inc. in March 2018. The company maintains its headquarters in Lehi, Utah.
Show more...
CEO
Ian Geran Jenkins
Employees
10
Country
United States
ISIN
US3570511010

Listings

OTC Link
US
FRLI

0 Comments

Share your thoughts

FAQ

What is Frelii stock price today?▼
The current price of FRLI is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Frelii stock price performance more closely on the chart.
What is Frelii stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Frelii stocks are traded under the ticker FRLI.
Is Frelii stock price growing?▼
FRLI stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Frelii has showed a +0% increase.
What is Frelii market cap?▼
Today Frelii has the market capitalization of 5,346.8
What were Frelii earnings last quarter?▼
FRLI earnings for the last quarter are -0.06 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Frelii revenue for the last year?▼
Frelii revenue for the last year amounts to 36,000 USD.
What is Frelii net income for the last year?▼
FRLI net income for the last year is -5.55M USD.
How many employees does Frelii have?▼
As of September 05, 2026, the company has 10 employees.
In which sector is Frelii located?▼
Frelii operates in the Health & Wellness sector.
When did Frelii complete a stock split?▼
The last stock split for Frelii was on March 08, 2017 with a ratio of 1:1000.
Where is Frelii headquartered?▼
Frelii is headquartered in Lehi, United States.